Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment

Lymphangioleiomyomatosis (LAM) is a rare systemic neoplastic disease that exclusively happens in women. Studies focusing on LAM and tuberous sclerosis complex (TSC) have made great progress in understanding the pathogenesis and searching for treatment. The inactive mutation of TSC1 or TSC2 is found...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xixi, Cai, Hui, Yang, Chengyu, Xue, Xiaomin, Wang, Jian, Mo, Yuqing, Zhu, Mengchan, Zhu, Guiping, Ye, Ling, Jin, Meiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542236/
https://www.ncbi.nlm.nih.gov/pubmed/33072782
http://dx.doi.org/10.3389/fmed.2020.554134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542236/
https://www.ncbi.nlm.nih.gov/pubmed/33072782
http://dx.doi.org/10.3389/fmed.2020.554134

Ejemplares similares